We showed that higher FSHR and LHCGR expression are associated with early stage, low grade ovarian cancer and that FSHR and LHCGR expression is reduced in HGSOC compared to benign ovarian tumors. The gene discussed is FSHR; the disease is ovarian benign neoplasm.